Greater impact from programs like 340B and site-neutrality, as well as, an emphasis on the economies of scale and economies of intelligence, can assist community oncology practices in delivering high-quality care, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
Greater impact from programs like 340B and site-neutrality, as well as, an emphasis on the economies of scale and economies of intelligence, can assist community oncology practices in delivering high-quality care, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
Transcript
With more patients being treated in the community setting, how are partnerships like OneOncology of growing importance?
Partnerships, whether it’s with OneOncology or anyone who professes to do stuff like we do, are increasingly more important for the future of community oncology. The economies of scale and economies of intelligence necessary to treat patients in the community setting in the future is so very critical, and models like OneOncology deliver that. The economies of scale to drive greater cost efficiencies and improve the cost effectiveness and affordability of patients, as well as, the economies of intelligence which drive real information, real analytics, and real insights that help us advance the science and the care for cancer, are really critical going forward.
What are some recent policy changes that have impacted community practices, and how are practices maneuvering these changes?
There are policy and regulatory changes primarily at the local level that continue to stand in the way of great patient care from time to time, but maybe what’s even most important is the regulatory and policy changes that haven’t happened. There are real improvements necessary to bring balance and perspective to community oncology. Things like 340B [drug pricing program] and site-neutrality, which really haven’t had the kind of action they deserve, would begin to bring better affordability and greater effectiveness for community oncology in the marketplace today.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More
Getting to Know Dr Shauna Downs, Public Health Nutritionist
February 23rd 2024Shauna Downs, PhD, MS, is an associate professor in the Department of Health Behavior, Society, and Policy at the Rutgers School of Public Health. A former figure skater, her research now focuses on interventions to promote healthy and sustainable food choices and exploring how our changing climate, food systems, diet, and nutrition are inextricably linked.
Read More